Table 1.
Baseline characteristics CCTA and SPECT/CMR cohorts
| CCTA | SPECT/CMR | |
|---|---|---|
| N | 6808 | 3381 |
| Age [mean (SD)] | 56.03 (12.34) | 61.93 (12.14) |
| Female sex (%) | 2253 (33.1) | 1394 (41.2) |
| Hypercholesterolaemia (%) | 2719 (39.9) | 2324 (68.7) |
| Hypertension (%) | 1084 (15.9) | 2016 (59.6) |
| Diabetes mellitus (%) | 654 (9.6) | 733 (21.7) |
| Atrial fibrillation (%) | 1280 (18.8) | 358 (10.6) |
| Platelet aggregation inhibitor use (%) | ||
| 0 | 3856 (64.2) | 1101 (38.1) |
| 1 or more | 2151 (38.5) | 1790 (61.9) |
| Cholesterol (mmol/L) [median (IQR)] | 5.20 (4.40–6.10) | 4.90 (4.10–5.90) |
| C-reactive Protein (mg/L) [median (IQR)] | 2.70 (1.20–9.30) | 4.90 (1.83–33.00) |
| HDL cholesterol (mmol/L) [median (IQR)] | 1.28 (1.07–1.53) | 1.26 (1.04–1.53) |
| LDL cholesterol (mmol/L) [median (IQR)] | 3.10 (2.40–3.90) | 2.70 (2.10–3.60) |
| Creatinine (µmol/L) [median (IQR)] | 94.00 (80.00–111.00) | 92.00 (81.00–106.00) |
| BMI [median (IQR)] | 25.86 (23.41–28.91) | 26.40 (23.71–29.45) |
| Systolic blood pressure (mmHg) [median (IQR)] | 135.00 (122.00–150.00) | 138.00 (121.00–156.00) |
| Mean arterial pressure (mmHg) [median (IQR)] | 99.00 (91.00–108.00) | 97.00 (87.00–107.00) |
| Diastolic blood pressure (mmHg) [median (IQR)] | 81.00 (74.00–89.00) | 80.00 (70.00–86.00) |